- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有53家主力机构披露2025-06-30报告期持股数据，持仓量总计4326.76万股，占流通A股4.71%
- 波段诊断：
-
技术面诊股
诊断结果：5.0技术面打败了12%的股票
技术面评分前10的股票
近期的平均成本为53.44元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为53.44元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"53.44","date":1762935969,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2025.11.13","stock":"3.31","trade":"1.58","ind":"1.78"},{"date":"2025.11.12","stock":"0.43","trade":"0.46","ind":"-0.36"},{"date":"2025.11.11","stock":"-3.00","trade":"0.64","ind":"-1.03"},{"date":"2025.11.10","stock":"0.47","trade":"1.26","ind":"0.18"},{"date":"2025.11.07","stock":"-0.80","trade":"-0.31","ind":"-0.36"},{"date":"2025.11.06","stock":"-2.09","trade":"-0.47","ind":"1.73"},{"date":"2025.11.05","stock":"-2.22","trade":"0.13","ind":"0.37"},{"date":"2025.11.04","stock":"-20.00","trade":"-1.91","ind":"-1.71"},{"date":"2025.11.03","stock":"5.29","trade":"0.77","ind":"0.19"},{"date":"2025.10.31","stock":"4.39","trade":"3.64","ind":"-1.14"},{"date":"2025.10.30","stock":"8.51","trade":"-1.21","ind":"-1.16"},{"date":"2025.10.29","stock":"1.39","trade":"0.27","ind":"1.95"},{"date":"2025.10.28","stock":"-0.64","trade":"-0.37","ind":"-0.44"},{"date":"2025.10.27","stock":"13.61","trade":"0.79","ind":"1.51"},{"date":"2025.10.24","stock":"-0.14","trade":"-0.38","ind":"2.02"},{"date":"2025.10.23","stock":"-2.33","trade":"-1.12","ind":"0.22"},{"date":"2025.10.22","stock":"1.71","trade":"0.67","ind":"-0.62"},{"date":"2025.10.21","stock":"1.10","trade":"1.33","ind":"2.06"},{"date":"2025.10.20","stock":"4.60","trade":"0.37","ind":"0.98"},{"date":"2025.10.17","stock":"0.52","trade":"-1.01","ind":"-3.04"},{"date":"2025.10.16","stock":"-3.41","trade":"0.19","ind":"-0.25"}]
常山药业,深证成指,化学制药指数
压力支撑
该股压力位为52.84元，支撑位为51.34元。
[{"text":"\u538b\u529b\u4f4d","value":"52.84","date":1762963200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"51.34","date":1762963200,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.3资金面打败了17%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：11月13日 20:34
| 机构今日流向(万元) | 1689.05 | 机构5日流向(万元) | 1502.26 |
| 机构10日流向(万元) | -203.75 | 机构20日流向(万元) | -12201.35 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1013.03万股，其中基金净减仓10家，主力净增仓28家，暂未发现中长期投资价值。
截止2025-06-30，共53家主力机构（基金50家，一般法人3家），持仓量总计4326.76万股，占流通A股4.71%
其中，基金持仓与2024-12-31相比：
增仓：2家 ，增持 4.90万股
减仓：12家 ，减持 24.43万股
新出现在主力名单中：35家 ，持有133.22万股
从主力名单中消失：7家 ，原持有13.81万股
其中，基金持仓与2024-12-31相比：
增仓：2家 ，增持 4.90万股
减仓：12家 ，减持 24.43万股
新出现在主力名单中：35家 ，持有133.22万股
从主力名单中消失：7家 ，原持有13.81万股
消息面诊股
诊断结果：5.5消息面打败了31%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 常山药业：艾本那肽完成审评的时间存在不确定性
2025-11-12 - 常山药业：公司将持续做好经营管理工作，提升公司盈利
2025-11-12 - 常山药业：《药品注册管理办法》中没有关于补充资料形
2025-11-12 - 常山药业：艾本那肽上市申请不适用优先审评审批程序
2025-11-12 - 常山药业：艾本那肽后续审评进展请以未来公示信息为准
2025-11-12 - 常山药业：艾本那肽下一阶段是补充资料审评阶段
2025-11-12 - 常山药业：11月11日获融资买入1.19亿元
2025-11-12 - 常山药业（截止2025年11月10日）股东人数为5
2025-11-11 - 常山药业：11月10日获融资买入1.22亿元
2025-11-11 - 常山药业：11月7日获融资买入1.84亿元
2025-11-10
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-10 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 一般消息 | 募资投向 | 2025-07-07 | |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-27 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
| 利好 | 业绩预告 | 预计减亏 | 2025-04-22 |
| 利好 | 业绩预告 | 预计减亏 | 2025-01-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：8.0行业面打败了90%的股票
化学制药行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2025.11.13","price":"1.78","value":"1.58"},{"date":"2025.11.12","price":"-0.36","value":"0.46"},{"date":"2025.11.11","price":"-1.03","value":"0.64"},{"date":"2025.11.10","price":"0.18","value":"1.26"},{"date":"2025.11.07","price":"-0.36","value":"-0.31"},{"date":"2025.11.06","price":"1.73","value":"-0.47"},{"date":"2025.11.05","price":"0.37","value":"0.13"},{"date":"2025.11.04","price":"-1.71","value":"-1.91"},{"date":"2025.11.03","price":"0.19","value":"0.77"},{"date":"2025.10.31","price":"-1.14","value":"3.64"},{"date":"2025.10.30","price":"-1.16","value":"-1.21"},{"date":"2025.10.29","price":"1.95","value":"0.27"},{"date":"2025.10.28","price":"-0.44","value":"-0.37"},{"date":"2025.10.27","price":"1.51","value":"0.79"},{"date":"2025.10.24","price":"2.02","value":"-0.38"},{"date":"2025.10.23","price":"0.22","value":"-1.12"},{"date":"2025.10.22","price":"-0.62","value":"0.67"},{"date":"2025.10.21","price":"2.06","value":"1.33"},{"date":"2025.10.20","price":"0.98","value":"0.37"},{"date":"2025.10.17","price":"-3.04","value":"-1.01"},{"date":"2025.10.16","price":"-0.25","value":"0.19"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 富祥药业 | 75.00% | 55.14% | 5.7分 |
| 2 | *ST景峰 | 45.36% | 12.98% | 5.9分 |
| 3 | 宏源药业 | 29.78% | 11.94% | 5.4分 |
| 4 | 亨迪药业 | 23.75% | 6.66% | 5.5分 |
| 5 | 南新制药 | 22.43% | 10.51% | 5.4分 |
| 6 | 广济药业 | 22.14% | 5.85% | 6.3分 |
| 8 | 民生健康 | 19.01% | 10.72% | 6.4分 |
| 10 | 前沿生物 | 18.03% | 12.43% | 5.8分 |
| 12 | 通化金马 | 16.85% | 3.09% | 6.2分 |
| 14 | 亚太药业 | 15.63% | 1.04% | 6.2分 |
| 16 | 尔康制药 | 14.12% | 10.92% | 6.6分 |
| 18 | - | 13.18% | 8.80% | 分 |
| 20 | 司太立 | 12.36% | 17.71% | 6.4分 |
| 22 | ST天圣 | 11.43% | 3.02% | 5.3分 |
| 24 | 华仁药业 | 11.04% | 4.93% | 6.7分 |
| 26 | *ST三圣 | 10.90% | 6.79% | 5.2分 |
| 28 | 海翔药业 | 10.51% | 0.96% | 5.8分 |
| 30 | 东亚药业 | 10.27% | -0.14% | 5.5分 |
| 32 | 威尔药业 | 9.81% | 3.61% | 6.5分 |
| 34 | 多瑞医药 | 9.76% | -0.27% | 5.4分 |
| 36 | 联环药业 | 9.44% | 5.69% | 6.2分 |
| 38 | 立方制药 | 9.24% | 9.01% | 6.5分 |
| 40 | 易明医药 | 8.98% | 2.26% | 5.9分 |
| 42 | 神奇制药 | 8.85% | 5.84% | 6.5分 |
| 44 | 莎普爱思 | 8.09% | 4.34% | 6.3分 |
| 46 | 津药药业 | 7.97% | 3.00% | 6.2分 |
| 48 | 东诚药业 | 7.59% | 1.03% | 6.4分 |
| 50 | 福安药业 | 7.26% | 2.60% | 6.0分 |
| 52 | 鲁抗医药 | 6.89% | 3.43% | 6.7分 |
| 54 | 金陵药业 | 6.73% | 2.76% | 6.6分 |
| 56 | 百济神州 | 6.62% | 9.76% | 6.0分 |
| 58 | 灵康药业 | 6.48% | 1.59% | 5.8分 |
| 60 | 山河药辅 | 6.24% | 2.76% | 5.4分 |
| 62 | 苑东生物 | 5.89% | 1.94% | 6.2分 |
| 64 | 天宇股份 | 5.64% | 4.49% | 5.6分 |
| 66 | 河化股份 | 5.22% | 1.73% | 6.5分 |
| 68 | 丰原药业 | 5.14% | 2.81% | 6.2分 |
| 70 | 奥锐特 | 4.71% | 1.79% | 5.7分 |
| 72 | 海南海药 | 4.59% | 0.65% | 6.2分 |
| 74 | 东北制药 | 4.27% | 5.40% | 6.9分 |
| 76 | 润都股份 | 4.15% | 5.64% | 6.2分 |
| 78 | 华北制药 | 4.02% | 0.81% | 6.1分 |
| 80 | - | 3.93% | 1.40% | 分 |
| 82 | 天新药业 | 3.78% | 2.91% | 5.4分 |
| 84 | 西点药业 | 3.62% | 1.12% | 5.8分 |
| 86 | 共同药业 | 3.54% | 3.40% | 6.2分 |
| 88 | 川宁生物 | 3.46% | 0.18% | 5.6分 |
| 90 | 本立科技 | 3.41% | 1.61% | 6.0分 |
| 92 | 华润双鹤 | 3.25% | 2.07% | 6.8分 |
| 94 | 富士莱 | 3.20% | -0.31% | 5.3分 |
| 96 | 海辰药业 | 2.67% | 3.92% | 5.6分 |
| 98 | 仙琚制药 | 2.26% | 4.84% | 6.6分 |
| 100 | 千红制药 | 2.11% | 1.66% | 6.5分 |
| 102 | 同和药业 | 2.02% | 5.14% | 6.2分 |
| 104 | 花园生物 | 1.79% | 4.63% | 6.4分 |
| 106 | 昂利康 | 1.71% | 13.45% | 6.3分 |
| 108 | 能特科技 | 1.30% | 3.18% | 6.7分 |
| 110 | 京新药业 | 0.87% | 2.31% | 6.3分 |
| 112 | 首药控股 | 0.59% | -1.41% | 5.4分 |
| 114 | 圣诺生物 | 0.41% | -0.48% | 6.1分 |
| 116 | 微芯生物 | 0.27% | -1.12% | 5.8分 |
| 118 | 国邦医药 | 0.00% | 5.53% | 6.4分 |
| 120 | 迪哲医药 | -0.18% | 6.29% | 6.2分 |
| 122 | 丽珠集团 | -0.45% | 2.34% | 6.2分 |
| 124 | 辰欣药业 | -0.66% | 1.20% | 5.7分 |
| 126 | 国药现代 | -0.74% | 2.78% | 6.2分 |
| 128 | 九典制药 | -1.05% | 2.98% | 6.1分 |
| 130 | 健友股份 | -1.24% | 3.30% | 6.1分 |
| 132 | 海森药业 | -1.92% | 1.07% | 5.8分 |
| 134 | 科源制药 | -2.43% | 1.55% | 5.7分 |
| 136 | 恩华药业 | -3.16% | 3.29% | 6.4分 |
| 138 | 小方制药 | -3.96% | -1.73% | 5.4分 |
| 140 | 海创药业 | -4.35% | 0.96% | 5.2分 |
| 142 | 吉贝尔 | -4.45% | -3.18% | 5.1分 |
| 144 | 恒瑞医药 | -4.91% | 1.83% | 6.4分 |
| 146 | 泰恩康 | -5.09% | -0.67% | 4.4分 |
| 148 | 永安药业 | -6.05% | 2.55% | 5.4分 |
| 150 | 贝达药业 | -7.36% | -0.24% | 5.4分 |
| 152 | 翰宇药业 | -7.87% | -3.84% | 6.0分 |
| 154 | 盟科药业 | -9.50% | 3.48% | 5.5分 |
| 156 | 广生堂 | -16.14% | -1.40% | 4.8分 |
| 158 | 必贝特 | - | -6.72% | 3.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 120/219 ， 142/219。
[{"date":"2025-09-30","value":"-2.91","vol":"1.46"},{"date":"2025-06-30","value":"-1.88","vol":"1.21"},{"date":"2025-03-31","value":"0.24","vol":"-0.17"},{"date":"2024-12-31","value":"-14.79","vol":"19.51"},{"date":"2024-09-30","value":"0.40","vol":"4.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.91 | -1.88 | 0.24 | -14.79 | 0.40 |
| 行业(%) | 1.46 | 1.21 | -0.17 | 19.51 | 4.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"15.91","vol":"49.47"},{"date":"2025-06-30","value":"14.54","vol":"49.43"},{"date":"2025-03-31","value":"23.10","vol":"49.23"},{"date":"2024-12-31","value":"16.10","vol":"50.77"},{"date":"2024-09-30","value":"18.06","vol":"50.51"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
15.91 | 14.54 | 23.10 | 16.10 | 18.06 |
| 行业(%) | 49.47 | 49.43 | 49.23 | 50.77 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 117/219 ， 145/219。
[{"date":"2025-09-30","value":"-13.11","vol":"141.76"},{"date":"2025-06-30","value":"-13.42","vol":"78.53"},{"date":"2025-03-31","value":"-12.10","vol":"-0.84"},{"date":"2024-12-31","value":"-26.92","vol":"17.76"},{"date":"2024-09-30","value":"-31.20","vol":"45.69"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-13.11 | -13.42 | -12.10 | -26.92 | -31.20 |
| 行业(%) | 141.76 | 78.53 | -0.84 | 17.76 | 45.69 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-714.77","vol":"-5.21"},{"date":"2025-06-30","value":"37.98","vol":"56.29"},{"date":"2025-03-31","value":"106.13","vol":"-21.21"},{"date":"2024-12-31","value":"79.88","vol":"-20.55"},{"date":"2024-09-30","value":"101.88","vol":"-32.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-714.77 | 37.98 | 106.13 | 79.88 | 101.88 |
| 行业(%) | -5.21 | 56.29 | -21.21 | -20.55 | -32.33 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 130/219 ， 143/219。
[{"date":"2025-09-30","value":"0.15","vol":"0.31"},{"date":"2025-06-30","value":"0.11","vol":"0.21"},{"date":"2025-03-31","value":"0.06","vol":"0.10"},{"date":"2024-12-31","value":"0.23","vol":"0.43"},{"date":"2024-09-30","value":"0.17","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.15 | 0.11 | 0.06 | 0.23 | 0.17 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.42","vol":"1.95"},{"date":"2025-06-30","value":"0.32","vol":"1.31"},{"date":"2025-03-31","value":"0.15","vol":"0.67"},{"date":"2024-12-31","value":"0.57","vol":"3.22"},{"date":"2024-09-30","value":"0.42","vol":"2.18"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.42 | 0.32 | 0.15 | 0.57 | 0.42 |
| 行业(次) | 1.95 | 1.31 | 0.67 | 3.22 | 2.18 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-16.27","vol":"4.36"},{"date":"2025-06-30","value":"30.15","vol":"2.81"},{"date":"2025-03-31","value":"39.81","vol":"-28.76"},{"date":"2024-12-31","value":"-38.14","vol":"-371.46"},{"date":"2024-09-30","value":"-23.56","vol":"-9.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -16.27 | 30.15 | 39.81 | -38.14 | -23.56 |
| 行业 | 4.36 | 2.81 | -28.76 | -371.46 | -9.87 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.31","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.21","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.31 | - | 3.21 | - |
| 行业 | 0.00 | 1.72 | 0.00 | 1.99 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 88/219 ， 79/219。
[{"date":"2025-09-30","value":"0.87","vol":"3.49"},{"date":"2025-06-30","value":"0.79","vol":"3.67"},{"date":"2025-03-31","value":"0.82","vol":"3.59"},{"date":"2024-12-31","value":"0.91","vol":"3.34"},{"date":"2024-09-30","value":"1.13","vol":"3.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.87 | 0.79 | 0.82 | 0.91 | 1.13 |
| 行业 | 3.49 | 3.67 | 3.59 | 3.34 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.24","vol":"2.74"},{"date":"2025-06-30","value":"0.23","vol":"2.89"},{"date":"2025-03-31","value":"0.25","vol":"2.81"},{"date":"2024-12-31","value":"0.23","vol":"2.64"},{"date":"2024-09-30","value":"0.31","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.24 | 0.23 | 0.25 | 0.23 | 0.31 |
| 行业 | 2.74 | 2.89 | 2.81 | 2.64 | 2.92 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 65/219 ， 8/219。
[{"date":"2025-09-30","value":"68.26","vol":"33.75"},{"date":"2025-06-30","value":"66.97","vol":"33.79"},{"date":"2025-03-31","value":"66.14","vol":"34.04"},{"date":"2024-12-31","value":"66.04","vol":"34.19"},{"date":"2024-09-30","value":"62.19","vol":"33.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
68.26 | 66.97 | 66.14 | 66.04 | 62.19 |
| 行业(%) | 33.75 | 33.79 | 34.04 | 34.19 | 33.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.10","vol":"0.94"},{"date":"2025-06-30","value":"1.98","vol":"0.88"},{"date":"2025-03-31","value":"1.92","vol":"1.46"},{"date":"2024-12-31","value":"1.91","vol":"0.84"},{"date":"2024-09-30","value":"1.60","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.10 | 1.98 | 1.92 | 1.91 | 1.60 |
| 行业(%) | 0.94 | 0.88 | 1.46 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"2.34","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.18","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-12.40","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-2.49","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]